Tabuteau, Herriot

Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial

Tabuteau, H., Jones, A., Anderson, A., Jacobson, M., & Iosifescu, D. V. (2022) · American Journal of Psychiatry

Treatment of Major DepressionPharmacological Receptor Mechanisms and Effects

Cited by 140

Efficacy and Safety of AXS-05 (Dextromethorphan-Bupropion) in Patients With Major Depressive Disorder

Iosifescu, D. V., Jones, A., O’Gorman, C., Streicher, C., Feliz, S., Fava, M., & Tabuteau, H. (2022) · The Journal of Clinical Psychiatry

Treatment of Major DepressionPharmacological Receptor Mechanisms and Effects

Cited by 135

Improvement in Anxiety Symptoms in Depressed Patients Treated With AXS-05 (DEXTROMETHORPHAN-BUPROPION): Results From the Evolve Open-Label, Long-Term Study

Jones, A., Streicher, C., Alter, S., Thomas, Z., & Tabuteau, H. (2023) · CNS Spectrums

Treatment of Major DepressionPharmacological Receptor Mechanisms and Effects

Cited by 5